News from glenmark pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

16 Sep, 2019, 13:00 BST Glenmark Receives Orphan Drug Designation for GBR 1342, a Bispecific Antibody Candidate Under Evaluation for the Treatment of Multiple Myeloma

Glenmark Pharmaceuticals (Glenmark), a research-led, integrated global pharmaceutical company, today announced that the U.S. Food and Drug...


06 Aug, 2018, 12:00 BST Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers

Glenmark Pharmaceuticals S.A. and Harbour BioMed announced today that they have entered into an exclusive license agreement for the Greater China...


09 Aug, 2017, 10:40 BST New Survey Reveals Low Level of Awareness of Common Contagious Childhood Skin Condition

Less than half of UK mums have heard of 'water warts' despite them affecting up to 11% of children and having a substantial impact on quality of life ...


15 Sep, 2015, 11:48 BST Glenmark's Bi-Specific Antibody - GBR 1302 to Enter Phase I Trials

- GBR 1302, a HER2xCD3 bi-specific antibody has successfully completed the preclinical evaluation phase - Preclinically, GBR 1302 has demonstrated...


24 Feb, 2015, 12:06 GMT Glenmark's Goa and Nashik Facilities Conferred the Prestigious Greentech Environment Gold Award - 2015

Two manufacturing facilities of Glenmark located in Goa and Nashik bagged the prestigious 'Greentech Environment Gold Award - 2015' for Excellence in ...


17 Sep, 2014, 16:10 BST Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study

Glenmark's first in class TRPA1 antagonist, GRC 17536, has shown positive data in a Phase 2a proof of concept study in patients with painful diabetic ...


24 Jul, 2014, 15:20 BST Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15

Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights India Business grew by 20.87% to Rs. 3,971.59 Mn US Business grew...


04 Jun, 2014, 10:51 BST Glenmark Pharmaceuticals Inaugurates New Antibody Manufacturing Facility in La Chaux-de-Fonds, Switzerland

- State-of-the-art Manufacturing Facility for Supply of Clinical Trial Material - With the Facility Glenmark has end-to-end Capabilities for the...


29 Apr, 2014, 12:23 BST Glenmark's novel monoclonal antibody GBR 900 for treatment of chronic pain entering human trials

GBR 900 is a first in class monoclonal antibody for the treatment of chronic pain targeting TrkA, the receptor of nerve growth factor (NGF) The...